Nobody knows:
What novel compounds form during the oxidative hydrothermal dissolution step?
What residual catalysts or incomplete breakdown products remain in the yeast output?
What happens when children consume these compounds chronically, over years or decades?
How does the body processes these entirely novel food-like substances?
What interactions occur with the gut microbiome, medications, or other dietary components?
Why Microplastics in Brains Is a Very Bad Idea
Can’t believe we have to go here.
Neurodevelopmental disruption in children
Reduced fertility and reproductive abnormalities
Metabolic disorders including obesity and diabetes
Immune system dysregulation
Increased cancer risk
The particles themselves also cause mechanical and inflammatory damage. The immune system recognizes them as foreign bodies and mounts a chronic inflammatory response it can never win since the plastic doesn’t degrade, so the inflammation never resolves.
This persistent neuroinflammation is implicated in everything from depression to dementia.
Follow the Money
The funding trail on projects like this is rarely accidental. Academic labs don’t pursue “turn plastic into food” without someone seeing a commercial benefit. The questions worth asking:
Who funded this research?
What patents have been filed?
Who benefits from normalizing “plastic is food”?
The pattern is familiar: academic lab develops “solution” to manufactured crisis → patents filed → startup spun out of the university → regulatory frameworks gradually adjusted to accommodate the new product → what was once unthinkable becomes mandatory.
We’ve Seen This Movie Before
There’s nothing new about industrialists trying to convert toxic waste streams into things people put in their bodies. John D. Rockefeller’s Standard Oil dominated petroleum refining in the late 19th and early 20th centuries and refining crude oil produces enormous quantities of byproducts that had no obvious market.
Rather than treat these as costly waste disposal problems, Rockefeller poured capital into what became the modern petrochemical and pharmaceutical industries, converting petroleum leftovers into solvents, synthetic chemicals, and eventually the foundation of allopathic medicine itself.
The entire pharmaceutical-industrial complex from aspirin’s acetylated origins to the petrochemically-derived excipients in every pill traces back to the question of what to do with all that leftover sludge. It wasn’t a health initiative. It was waste management with a markup. µBites is the same instinct wearing a CRISPR lab coat: don’t ban the waste stream, rebrand it as nutrition and sell it back to the public.
The Imperial College Guy Already Killed It
Hallett also pointed out the obvious: we already know how to recycle plastic. The problem isn’t technical, it’s logistical and economic. Virgin plastic is too cheap, the waste collection is too fragmented, and manufacturers face no real accountability for the end-of-life fate of their products. You don’t need CRISPR yeast. You need producer responsibility laws.
The Real Story
Nobody is going to eat plastic cookies. This isn’t about feeding anyone. It’s about maintaining the intellectual and institutional infrastructure that treats every crisis as an engineering problem rather than a political and economic one.
The plastic crisis exists because petrochemical companies decided it was more profitable to externalize disposal costs onto municipalities, ecosystems, and human bodies than to design genuinely recyclable or biodegradable materials. The solution isn’t to genetically engineer yeast that can digest their toxic waste stream and call it dessert.